Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Biederman

Showing results (481-490 of 581) with videos related to

Pageof 59
Sort By:
Journal of Clinical Psychopharmacology|December 20, 2018
Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical TrialCraig Surman, Atilla Ceranoglu, Carrie Vaudreuil, et al.
The Journal of Clinical Psychiatry|August 31, 2016
Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct DisorderTimothy E Wilens, Joseph Biederman, MaryKate Martelon, et al.
Pediatrics|November 29, 2002
Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorderJoseph Biederman, John H Heiligenstein, Douglas E Faries, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 11, 2002
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trialChristopher J Kratochvil, John H Heiligenstein, Ralf Dittmann, et al.
Biological Psychiatry|December 25, 2010
Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometryLarry J Seidman, Joseph Biederman, Lichen Liang, et al.
Epilepsy & Behavior : E&B|March 21, 2007
Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorderJoseph Gonzalez-Heydrich, Alice Dodds, Jane Whitney, et al.
The Journal of Clinical Psychiatry|January 8, 2013
A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorderIris Manor, Rachel Ben-Hayun, Judith Aharon-Peretz, et al.
Journal of Autism and Developmental Disorders|April 21, 2018
High Risk for Severe Emotional Dysregulation in Psychiatrically Referred Youth with Autism Spectrum Disorder: A Controlled StudyGagan Joshi, Janet Wozniak, Maura Fitzgerald, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 27, 2004
Risk of substance use disorders in adolescents with bipolar disorderTimothy E Wilens, Joseph Biederman, Anne Kwon, et al.
The American Journal of Psychiatry|February 2, 2006
Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy studyConstance M Moore, Joseph Biederman, Janet Wozniak, et al.
Pageof 59

Showing results (481-490 of 581) with videos related to

Sort By:
Pageof 59
Journal of Clinical Psychopharmacology|December 20, 2018
Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical TrialCraig Surman, Atilla Ceranoglu, Carrie Vaudreuil, et al.
The Journal of Clinical Psychiatry|August 31, 2016
Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct DisorderTimothy E Wilens, Joseph Biederman, MaryKate Martelon, et al.
Pediatrics|November 29, 2002
Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorderJoseph Biederman, John H Heiligenstein, Douglas E Faries, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 11, 2002
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trialChristopher J Kratochvil, John H Heiligenstein, Ralf Dittmann, et al.
Biological Psychiatry|December 25, 2010
Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometryLarry J Seidman, Joseph Biederman, Lichen Liang, et al.
Epilepsy & Behavior : E&B|March 21, 2007
Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorderJoseph Gonzalez-Heydrich, Alice Dodds, Jane Whitney, et al.
The Journal of Clinical Psychiatry|January 8, 2013
A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorderIris Manor, Rachel Ben-Hayun, Judith Aharon-Peretz, et al.
Journal of Autism and Developmental Disorders|April 21, 2018
High Risk for Severe Emotional Dysregulation in Psychiatrically Referred Youth with Autism Spectrum Disorder: A Controlled StudyGagan Joshi, Janet Wozniak, Maura Fitzgerald, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 27, 2004
Risk of substance use disorders in adolescents with bipolar disorderTimothy E Wilens, Joseph Biederman, Anne Kwon, et al.
The American Journal of Psychiatry|February 2, 2006
Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy studyConstance M Moore, Joseph Biederman, Janet Wozniak, et al.
Pageof 59